EUVIMEDEUVIMED entdecken
Crossref

Alginate type and RGD density control myoblast phenotype

Jon A Rowley, David J Mooney

Journal of Biomedical Materials Research · 2002-05 · 60 (2) · 217-223

DOI: 10.1002/jbm.1287 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomedical Materials Research, online erschienen am 24.01.2002. Verfasst von Jon A Rowley und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, University of Michigan, Colleges of Engineering and Dentistry, Ann Arbor, Michigan, USA. Die Arbeit wurde bisher 402-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: NIGMS NIH HHS, NIDCR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alginates are being increasingly used for cell encapsulation and tissue engineering applications; however, these materials cannot specifically interact with mammalian cells. We have covalently modified alginates of varying monomeric ratio with RGD‐containing cell adhesion ligands using carbodiimide chemistry to initiate cell adhesion to these polymers. We hypothesized that we could control the function of cells adherent to RGD‐modified alginate hydrogels by varying alginate polymer type and cell adhesion ligand density, and we have addressed this possibility by studying the proliferation and differentiation of C2C12 skeletal myoblasts adherent to these materials. RGD density on alginates of varying monomeric ratio could be controlled over several orders of magnitude, creating a range of surface densities from 1–100 fmol/cm 2 . Myoblast adhesion to these materials was specific to the RGD ligand, because adhesion could be competed away with soluble RGD in a dose‐dependent manner. Myoblast proliferation and differentiation could be regulated by varying the alginate monomeric ratio and the density of RGD ligands at the substrate surface, and specific combinations of alginate type and RGD density were required to obtain efficient myoblast differentiation on these materials. © 2002 Wiley Periodicals, Inc. J Biomed Mater Res 60: 217–223, 2002; DOI 10.1002/jbm.1287

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlginatesCell AdhesionCell DifferentiationCell DivisionCell FusionCell LineExtracellular MatrixHexuronic AcidsHumansHydrogelsIodine RadioisotopesIsotope LabelingLigandsMuscle, SkeletalOligopeptidesPhenotype

Substanzen

AlginatesHexuronic AcidsHydrogelsIodine RadioisotopesLigandsOligopeptidesarginyl-glycyl-aspartic acidmannuronic acid

Autor:innen und Institutionen

  • Department of Biomedical Engineering, University of Michigan, Colleges of Engineering and Dentistry, Ann Arbor, Michigan, USA.

Förderung

  • NIGMS NIH HHS
  • NIDCR NIH HHS

Zitieren

APA

Rowley, J. A., & Mooney, D. J. (2002). Alginate type and RGD density control myoblast phenotype. Journal of Biomedical Materials Research, 60(2), 217-223. https://doi.org/10.1002/jbm.1287

Vancouver

Rowley JA, Mooney DJ. Alginate type and RGD density control myoblast phenotype. Journal of Biomedical Materials Research. 2002;60(2):217-223. doi:10.1002/jbm.1287

BibTeX
@article{Rowley2002,
  author = {Rowley, Jon A and Mooney, David J},
  title = {Alginate type and RGD density control myoblast phenotype},
  journal = {Journal of Biomedical Materials Research},
  year = {2002},
  volume = {60},
  number = {2},
  pages = {217--223},
  doi = {10.1002/jbm.1287}
}
Kostenlos starten →